TRUFFLE CAPITAL SASLuck factor —Luck data is unavailable for this scope.
Follow this organization across linked issuers and source filings.
Companies in disclosed relationships
1
Public filings
4
Net disclosed balance
€7,646,994.46
Latest filing
1 Jul 2026
Signals Pro
Illustrative example · simulated data, not results for this insider
Recent filings
| Date | Issuer | Gross reported value | Open |
|---|---|---|---|
| 1 Jul 2026 | AFFLUENT MEDICAL | Buy €2,599,998.24 Buy/sale net: €2,599,998.24 | Open |
| 4 Feb 2026 | AFFLUENT MEDICAL | Buy €4,999,997.34 Buy/sale net: €4,999,997.34 | Open |
| 21 Oct 2025 | AFFLUENT MEDICAL | Buy €21,999.36 Buy/sale net: €21,999.36 | Open |
| 24 Sept 2025 | AFFLUENT MEDICAL | Buy €24,999.52 Buy/sale net: €24,999.52 | Open |
Gross reported value
€2,599,998.24
Supporting information
AFFLUENT MEDICAL
Buy/sale net: €2,599,998.24
Gross reported value
€4,999,997.34
Supporting information
AFFLUENT MEDICAL
Buy/sale net: €4,999,997.34
Gross reported value
€21,999.36
Supporting information
AFFLUENT MEDICAL
Buy/sale net: €21,999.36
Gross reported value
€24,999.52
Supporting information
AFFLUENT MEDICAL
Buy/sale net: €24,999.52
Network and companies
1 distinct company in the disclosed relationships. Network coverage is a separate preview.
Identify the affected field and a source that supports the correction. Use the private contact for rights requests; do not attach identity documents unless necessary and requested.